Skip to main content

Woman's Estate Gets $425,000 in Bypass Surgery Death Suit

Woman's Estate Gets $425,000 in Bypass Surgery Death Suit

Introduction

The Medical University of South Carolina made a settlement of $425,000 to a woman's estate who died after getting a bypass surgery in 2017.

As per the court documents, a 43-year-old woman with a history of morbid obesity underwent gastric bypass surgery on October 6, 2017. A day after the surgery, the hospital staff noted she had blood clots. She suffered from hypotension and abdominal pain on October 8,  for which a medical emergency team was called. A CT scan revealed that the woman had a bowel obstruction and was then taken to the ICU, where she died within hours of the first emergency call.

A personal representative of the woman’s estate sued the Medical University for negligence, medical malpractice, and wrongful death. The state insurance reserve paid $425,000 to the claims and allegations asserted in the medical malpractice lawsuit.

A similar medical malpractice lawsuit was filed against a medical center in Seattle in 2015. The woman suffered a variety of injuries including impaired cognitive function, speech, memory, and mobility. She received nearly $14 million as a settlement for future economic losses and damages.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Millions Allocated to Combat Bronx Opioid Crisis

Categories: Opioids

Bronx Borough President, alongside key local and state leaders, announced the allocation of $6 million to create a new facility aimed at combating the…

GSK to Settle 80,000 Zantac Lawsuits for up to $2.2b

Categories: Zantac

GSK has agreed to pay up to $2.2 billion to settle the majority of pending U.S. state court lawsuits alleging that a discontinued version of the heartburn medication…

GSK CEO Strives to Resolve Zantac Litigation Drag on Shares

Categories: Zantac

GSK Plc’s CEO has made it a priority to ensure that the majority of the company’s employees remain focused on the company's core mission, rather than the ongoing…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!